🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to users administering products of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the platform has removed problematic material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of weight loss, positive reviews and step-by-step instructions for mixing or injecting at residence.

After moments of joining one group, a vendor posted WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, health issues or previous experience.

Item Details and Costs

Within these communities, messages show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly significant medical dangers”.